There are 14 resources available
Welcome and course overview
Presenter: J .Desai, AU, E. Garralda, ES, B. Ma, HK
Session: Opening and welcome
Resources:
Slides
Webcast
Importance of Phase I trials in drug development: Historical perspective
Presenter: L.L. Siu, CA
Session: Session 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
Current designs of Phase 1 clinical trials
Presenter: R. Plummer, UK
Session: Session 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
Limitation of current designs and future designs
Presenter: Josh C.C. Lin, TW
Session: Session 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
Targeted therapy, biomarkers, combinatorial approach
Presenter: D.Y. Oh, KR
Session: Session 2 - Step-by-step development of specific classes of drugs, patient selection, relevant biomarkers and pharmacodynamics
Resources:
Slides
Webcast
Immunotherapy, biomarkers, combinational approach
Presenter: D.S.W. Tan, SG
Session: Session 2 - Step-by-step development of specific classes of drugs, patient selection, relevant biomarkers and pharmacodynamics
Resources:
Slides
Webcast
Other agents: e.g. drug conjugates, hormonal agents, cell-based therapies,…
Presenter: A. Stathis, CH
Session: Session 2 - Step-by-step development of specific classes of drugs, patient selection, relevant biomarkers and pharmacodynamics
Resources:
Slides
Webcast
Patient selection: Genomic matching to Phase I trials, NGS, ctDNA, existing programmes
Presenter: T.A. Yap, US
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast
Safety and adverse events management
Presenter: B. Tran, AU
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast
Assessing efficacy in novel Phase I trials
Presenter: T. Shimizu, JP
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast